Abstract
Purpose
The authors compared multidetector-row computed tomography (MDCT) and endoscopic ultrasound (EUS) in the identification of pancreaticoduodenal endocrine tumours (PETs) in patients with multiple endocrine neoplasia type 1 (MEN 1).
Materials and methods
Fourteen consecutive patients (eight men and six women, aged 26–54 years) with MEN 1 underwent MDCT performed with a 4- (n=5) or 64- (n=9) detector-row system and EUS done with a radial transducer (7.5–20 MHz) within 7–28 days of each other. Prior to MDCT examination, patients were given 750 cc of water and asked to lie down in the right lateral decubitus for 15 min. Multiphase MDCT images were acquired both before and after the injection of nonionic iodinated contrast material (2 cc/kg) at an injection rate of 4 ml/s, with technical parameters and scan delay varying in relation to the system used. Images were all reconstructed at 3-mm intervals for the three phases (arterial, pancreatic and portal) and evaluated on a dedicated workstation.
Results
MDCT detected a total of 25 PETs (3–18 mm) in nine patients. Of these lesions, nine were situated within the duodenal wall and 16 in either the pancreatic head (n=3), body (n=7), or tail (n=6). Three additional lesions were detected retrospectively after EUS imaging. Most (18/22, 81%) were hypervascular nodules, and four appeared as either hypoattenuating or cystic lesions. EUS detected a total of 32 PETs (2–18 mm) in 11 patients. Most lesions (29/32, 90%) appeared hypoechoic and were situated in the duodenal wall (n=15) or in either the pancreatic head (n=10), body (n=6) or tail (n=1).
Conclusions
Our preliminary data indicate that MDCT is complementary to EUS in the identification of PETs in MEN-1 patients.
Riassunto
Obiettivo
Scopo del nostro lavoro è stato confrontare la tomografia computerizzata (TC) multistrato (TCMS) e l’eco-endoscopia (EUS) nella identificazione dei tumori endocrini pancreatico-duodenali (TEPD) in pazienti affetti da multiple endocrine neoplasia tipo 1 (MEN-1).
Materiali e metodi
Quattordici pazienti consecutivi (8 maschi, 6 femmine; 26–54 anni) affetti da MEN-1 sono stati sottoposti sia a TCMS, eseguita con 4 (n=5) o 64 file di detettori (n=9), che ad EUS eseguita con strumento radiale (7,5–20 MHz) entro 7–28 giorni. Gli esami TC sono stati acquisiti con tecnica multifasica previa distensione gastro-duodenale con acqua ed assunzione del decubito laterale destro (15 min), prima e dopo iniezione a bolo (4 ml/s) di mezzo di contrasto (MdC) iodato idro-solubile non ionico (2 cc/kg) con parametri tecnici e ritardi di scansione variabili in funzione del tipo di apparecchiatura. Le immagini sono state ricostruite con spessori identici (3 mm) per le 3 fasi (arteriosa, pancreatica e portale) ed analizzate su workstation dedicata.
Risultati
Alla TCMS sono state riscontrate 16 lesioni nodulari (5–18 mm) a livello del pancreas (3 testa, 7 corpo e 6 coda) e 9 (3–7 mm) a carico della parete duodenale in 9 pazienti. Delle 25 formazioni nodulari, 22 sono state identificate prospetticamente (18 iper-, 4 ipo-ecogene o cistiche) e 3 alla luce del dato endoscopico. All’eco-endoscopia sono state riscontrate 32 formazioni nodulari (29 ipo-, 3 iso-ecogene) in 11 pazienti. Di queste, 17 (4–18 mm) a livello del pancreas (10 testa, 6 corpo, 1 coda) e 15 (2–12 mm) a livello della parete duodenale.
Conclusioni
La TCMS rappresenta un utile complemento all’eco-endoscopia nella identificazione dei TEPD.
Similar content being viewed by others
References/Bibliografia
Thakker RD (2000) Multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am 29:541–567
Guo SS, Sawicki MP (2001) Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1. Mol Endocrinol 15:1653–1664
Brandi ML, Gagel RF, Angeli A et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 12:5658–5671
Benson L, Ljunghall S, Akerstrom G (1987) Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1. Am J Med 82:731–737
Doherty GM (2003) Multiple endocrine neoplasia type 1: duodenopancreatic tumors. Surg Oncol 12:135–143
Thomas-Marques L, Murat A, Delemer B et al (2006) Groupe des Tumeurs Endocrines (GTE) Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. Am J Gastroenterol 101:266–273
Wamsteker EJ, Gauger PG, Thompson NW, Scheiman JM (2003) EUS detection of pancreatic endocrine tumors in asymptomatic patients with type 1 multiple endocrine neoplasia. Gastrointest Endosc 58:531–535
Langer P, Kann PH, Fendrich V et al (2004) Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. World J Surg 28:1317–1322
Kouvaraki M, Shapiro S, Cote GJ et al (2006) Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J Surg 30:643–653
Helleman, Hennings J, Akerstrom G, Skogseid B (2005) Endoscopic ultrasonography for evaluation of pancreatic tumors in multiple endocrine neoplasia type 1. Br J Surg 92:1508–1512
Fidler JL, Fletcher JG, Reading CC et al (2003) Preoperative detection of pancreatic insulinomas on multiphasic helical CT. AJR Am J Roentgenol 181:775–780
Gouya H, Vignaux O, Augui J et al (2003) CT, endoscopic sonography and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentegenol 181:987–992
Liu Y, Song Q, ** HT et al (2009) The value of multidetector-row CT in the pre-operative detection of pancreatic insulinomas. Radiol Med 114:1232–1238
Gusmini S, Nicoletti R, Martinenghi C et al (2007) Arterial vs pancreatic phase: which is the best choice in evaluation of pancreatic endocrine tumours with multi-detector computed tomography (MDTC)? Radiol Med 112:999–1012
Zimmer T, Scherubl H, Faiss S et al (2000) Endoscopic ultrasonography of neuroendocrine tumours. Digestion 62:45–50
Trump D, Farren B, Wooding C et al (1996) Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Q J Med 89:653–659
Buscail L (1995) Endoscopic ultrasonography in pancreatobiliary disease using radial instruments. Gastrointest Endosc Clin N Am 5:781–787
Graziani R, Brandalise A, Bellotti M et al (2010) Imaging of neuroendocrine gastroenteropancreatic tumours. Radiol Med 115:1047–1064
Tublin ME, Tessler FN, Cheng SL et al (1999) Effect of injection rate of contrast medium on pancreatic and hepatic helical CT. Radiology 210:97–101
Sandstede JJ, Tschammler A, Beer M et al (2001) Optimization of automatic bolus tracking for timing of arterial phase of helical liver CT. Eur Radiol 11:1396–1400
Kann PH, Wirkus B, Keth A et al (2003) Pitfalls in endosonographic imaging of suspected insulinomas: pancreatic nodules of unknown dignity. Eur J Endocrinol 148:531–534
Triponez F, Goudet P, Dosseh D et al (2006) Is surgery beneficial for MEN 1 patients with small (< 2cm), non-functional pancreaticoduodenal endocrine tumors? An analysis of 65 patients from the GTE. World J Surg 30:654–666
Author information
Authors and Affiliations
Corresponding author
Additional information
The preliminary findings of this study were presented as an oral communication at the 2006 SIRM Congress. Radiol Med 111(Suppl 1) 2006
Rights and permissions
About this article
Cite this article
Camera, L., Paoletta, S., Mollica, C. et al. Screening of pancreaticoduodenal endocrine tumours in patients with MEN 1: multidetector-row computed tomography vs. endoscopic ultrasound. Radiol med 116, 595–606 (2011). https://doi.org/10.1007/s11547-011-0636-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-011-0636-2
Keywords
- Multiple endocrine neoplasia (MEN) 1
- Pancreaticoduodenal endocrine tumours
- Multidetector CT (MDCT)
- Endoscopic ultrasonography (EUS)